
Scanvio
AI-assisted ultrasound for early endometriosis diagnosis at initial gynecologic exams.
Date | Investors | Amount | Round |
---|---|---|---|
- | investor | €0.0 | round |
investor | €0.0 | round | |
investor investor | €0.0 | round | |
* | CHF150k | Grant | |
Total Funding | 000k |
Related Content
Scanvio focuses on enhancing early diagnosis of endometriosis through AI-assisted ultrasound technology, targeting millions of women affected by this condition. The company operates in the healthcare sector, specifically within the gynecological diagnostics market. By integrating machine learning expertise with advanced ultrasound techniques, Scanvio aims to provide a more accurate and timely diagnosis during the first gynecologic examination. This approach not only improves patient outcomes but also reduces the long-term healthcare costs associated with delayed diagnosis. The business model likely involves partnerships with healthcare providers and clinics, offering their technology as a service to improve diagnostic capabilities. Revenue generation may stem from licensing agreements or service fees for the use of their AI-driven diagnostic tools.
Keywords: endometriosis, AI, ultrasound, diagnosis, gynecology, healthcare, machine learning, women's health, early detection, medical technology.